EVALUATION OF COVID-19 VACCINES IN PRIMARY PREVENTION AGAINST INFECTIONS AND REDUCTION IN SEVERITY OF ILLNESS FOLLOWING THE OUTBREAK OF SARS-COV-2 OMICRON VARIANT IN SHANGHAI

被引：0
|
作者：
Yang, D. [1 ]
Weng, H. [2 ]
Song, Y. [1 ]
Li, J. [3 ]
Lu, X. [3 ]
Yang, W. [2 ]
Chen, Z. [4 ]
Xuan, J. [3 ]
Bai, C. [1 ]
Wang, Y. [5 ]
机构：
[1] Fudan Univ, Dept Pulm & Crit Care Med, Zhongshan Hosp, Shanghai, Peoples R China
[2] Suvalue Healthcare Sci Co Ltd, Shanghai, Peoples R China
[3] Shanghai Centennial Sci Co Ltd, Shanghai, Peoples R China
[4] Guangzhou Med Univ, Dept Clin Res Management Off, Affiliated Hosp 3, Guangzhou, Peoples R China
[5] Army Med Univ, Inst Surg Res, Daping Hosp,Wound Trauma Med Ctr, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH100
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [11] Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
    Ioannis Sitaras
    Henning Jacobsen
    Melissa M. Higdon
    William E. Dowling
    Naor Bar-Zeev
    Maria Deloria Knoll
    npj Vaccines, 7
  • [12] Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
    Sitaras, Ioannis
    Jacobsen, Henning
    Higdon, Melissa M.
    Dowling, William E.
    Bar-Zeev, Naor
    Knoll, Maria Deloria
    NPJ VACCINES, 2022, 7 (01)
  • [13] Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era
    McCreary, Erin K.
    Kip, Kevin E.
    Collins, Kevin
    Minnier, Tami E.
    Snyder, Graham M.
    Steiner, Ashley
    Meyers, Russell
    Borneman, Tina
    Adam, Michelle
    Thurau, Lauren
    Yealy, Donald M.
    Huang, David T.
    Bariola, J. Ryan
    Schmidhofer, Mark
    Wadas, Richard J.
    Angus, Derek C.
    Kip, Paula L.
    Marroquin, Oscar C.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (10):
  • [14] A comparison of severity of illness between the SARS-CoV-2 Omicron variant and Delta variant
    Ellis, Laura Peyton
    Hess, Olivia
    Huynh, Khoa Le Anh
    Bearman, Gonzalo
    Kang, Le
    Doern, Christopher D.
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2023, 3 (01):
  • [15] Enhancing Omicron Sublineage Neutralization: Insights From Bivalent and Monovalent COVID-19 Booster Vaccines and Recent SARS-CoV-2 Omicron Variant Infections
    Jeong, Hye Won
    Rollon, Rare
    Kim, Se-Mi
    Gil, Juryeon
    Casel, Mark Anthony
    Jang, Hyunwoo
    Choi, Jeong Ho
    Jang, Seung-Gyu
    Lazarte, Josea Carmel
    Kim, Hee-Sung
    Kim, Jun Hyoung
    Choi, Young Ki
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (10)
  • [16] Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
    Karim, Salim S. Abdool
    Karim, Quarraisha Abdool
    LANCET, 2021, 398 (10317): : 2126 - +
  • [17] COVID-19 severity from Omicron and Delta SARS-CoV-2 variants
    Wrenn, Jesse O.
    Pakala, Suman B.
    Vestal, Grant
    Shilts, Meghan H.
    Brown, Hunter M.
    Bowen, Sara M.
    Strickland, Britton A.
    Williams, Timothy
    Mallal, Simon A.
    Jones, Ian D.
    Schmitz, Jonathan E.
    Self, Wesley H.
    Das, Suman R.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (05) : 832 - 836
  • [18] Severity predictors of COVID-19 in SARS-CoV-2 variant, delta and omicron period; single center study
    Ogawa, Fumihiro
    Oi, Yasufumi
    Honzawa, Hiroshi
    Misawa, Naho
    Takeda, Tomoaki
    Kikuchi, Yushi M.
    Fukui, Ryosuke M.
    Tanaka, Katsushi M.
    Kano, Daiki
    Kato, Hideaki
    Abe, Takeru
    Takeuchi, Ichiro
    PLOS ONE, 2022, 17 (10):
  • [19] Patients with advanced pancreatic and biliary cancer appear vulnerable to SARS-CoV-2 Omicron variant: An observational study during the COVID-19 outbreak in Shanghai
    Han, Tao
    Chen, Lujun
    Gu, Jia
    Wu, Shen
    Maihemuti, Maiweilan
    Yang, Jue
    Wang, Hao
    Wu, Jun
    Zhang, Yue
    Cong, Yun
    Wang, Jiening
    Chen, Tingsong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [20] Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy
    Joshi, Gaurav
    Poduri, Ramarao
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
12345